Quality of Life with Cediranib in relapsed Ovarian Cancer: the ICON6 phase III randomised clinical trial

Stark, D orcid.org/0000-0002-6172-733X, Cook, A, Brown, J orcid.org/0000-0002-2719-7064 et al. (8 more authors) (2017) Quality of Life with Cediranib in relapsed Ovarian Cancer: the ICON6 phase III randomised clinical trial. Cancer, 123 (14). pp. 2752-2761. ISSN 0008-543X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society . This is an open access article under the terms of the Creative Commons Attribution License [https://creativecommons.org/licenses/by/4.0/], which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: chemotherapy; health-related quality of life; ovarian cancer
Dates:
  • Published: 15 July 2017
  • Accepted: 31 January 2017
  • Published (online): 24 March 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Feb 2017 16:16
Last Modified: 25 Jul 2017 11:43
Published Version: https://doi.org/10.1002/cncr.30657
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/cncr.30657

Share / Export

Statistics